Moneycontrol PRO

business

Ranbaxy likely to tie-up with MNC to source Diovan APIs

Diovan was the drug which was off-patented in September 2012 and Ranbaxy has a first-to-file (FTF) status over it. This means they will get six months of marketing exclusivity in the market.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections
ISO 27001 - BSI Assurance Mark